课题基金 / 基金详情

Mode of replication and pathogenicity of human herpesvirus 7

Mode of replication and pathogenicity of human herpesvirus 7
人疱疹病毒7型的复制方式和致病性
批准号:
06670329
负责人:
YAMADA Masao
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

YAMADA Masao的其他基金

相似基金

相关文献

中文摘要
翻译
人类疱疹病毒7号(HHV-7)是一种新的t淋巴性疱疹病毒,与HHV-6有相关性,但与HHV-6有显著差异。我们从健康成人的唾液样本中分离出几株临床分离株,它们被鉴定为HHV-7。建立了感染性滴定法和脐带血淋巴细胞获得高滴度无细胞病毒制剂的方法。比较分析HHV-6A、6B和7的一步生长曲线。在21个造血细胞系中,CD4+ CD8+ T细胞系SUP-T1是唯一支持HHV-7复制的细胞系。SUP-T1细胞中HHV-7病毒滴度与脐带血淋巴细胞中相似。用HHV-7感染SUP-T1细胞后,观察到感染性病毒的持续产生。培养物是感染细胞和未感染细胞的混合物,感染细胞的比例约为10%至20%。上清液中未检测到干扰素活性。然而,用外源性干扰素β处理培养物可显著减少病毒的产生,治愈了培养物的持续感染。没有检测到病毒产生、感染细胞或HHV-7基因组。我们利用SUP-T1细胞系和由SUP-T1建立的HIV携带者细胞系研究了HIV-1与HHV-7的相互作用。CD4抗原的表达在HIV-1携带者细胞系中完全下调。虽然HIV-1载体SUP-T1细胞与HHV-6的重复感染很容易完成,但相同的细胞完全抵抗HHV-7的重复感染。此外,用抗cd4单克隆抗体处理SUP-T1细胞可抑制HHV-7的生长。这些结果表明,HIV-1携带者SUP-T1细胞对HHV-7的抗性是由于细胞表面缺乏CD4抗原,并且HIV-1和HHV-7使用相同的分子,CD4抗原作为病毒受体。
英文摘要
Human Herpesvirus 7 (HHV-7), a new T-lymphotropic herpesvirus, is related to, but significantly different from HHV-6. We isolated several clinical isolates from saliva samples of healthy adults, and they were identified as HHV-7. We established a method for infectious titration and a method to obtain high titer cell-free virus preparation using cord blood lymphocytes. One-step growth curves of HHV-6A,6B,and 7 were comparatively analyzed. Among 21 hematopoietic cell lines, a CD4+ CD8+ T cell line, SUP-T1, was the only cell line that supported HHV-7 replication. Virus titers of HHV-7 in SUP-T1 cells were comparable to those in cord blood lymphocytes.Persistent production of infectious virus was observed after infection of SUP-T1 cells with HHV-7. The culture was the mixture of infected and uninfected cells with the ratio of the infected cells ranging around 10 to 20%. Interferon activity was not detected in the supernatant. However, the treatment of the culture with exogenous interferon beta dramatically reduced the production of virus and cured the culture of the persistent infection. No virus production, infected cell, or HHV-7 genome was detectable.We studied the interaction of HIV-1 and HHV-7 using the SUP-T1 cell line and a HIV carrier cell line established from SUP-T1. Expression of the CD4 antigen was completely downregulated in the HIV-1 carrier cell line. While superinfection of HIV-1 carrier SUP-T1 cells with HHV-6 was readily accomplished, the same cells were completely resistant to superinfection with HHV-7. Furthermore, treatment of SUP-T1 cells with anti-CD4 monoclonal antibodies inhibited the growth of HHV-7. These results suggest that resistance of HIV-1 carrier SUP-T1 cells to HHV-7 is due to the absence of the CD4 antigen on the cell surface and that HIV-1 and HHV-7 use the same molecule, the CD4 antigen, as the virus receptor.
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
Yamada M: "Resistance of HIV-1 carrier SUP-T1 cells to superinfection with human herpesvirus 7" AIDS Research Newsletter. 37. (1994)
Yamada M:“HIV-1 携带者 SUP-T1 细胞对人类疱疹病毒 7 重复感染的抵抗力”艾滋病研究通讯。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hayashi K.: "HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line(Si-IIA)" Jap.J Cancer Res.86(8). 808-818 (1994)
Hayashi K.:“静脉内接种 HTLV-II 感染的猿白细胞系 (Si-IIA) 后,日本白兔中诱导 HTLV-II 非整合性恶性淋巴瘤”Jap.J Cancer Res.86(8)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    Alternative splicing in disease genes
    Inhibitory Effects of Beta-herpesviruses on Hematopoiesis
    • 批准号:
      13670299
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      YAMADA Masao
    • 依托单位:
    Analysis of antigenic properties of human herpesvirus 7 and the host immune responses
    • 批准号:
      10670285
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1998
    • 负责人:
      YAMADA Masao
    • 依托单位:
    Dynamic mutations in genome, like triplet repeat expansion
    海外基金